June 29, 2011, 2:56 PM F.D.A. Panel Rejects Use of Avastin for Breast Cancer By ANDREW POLLACK Updated: An advisory committee to the Food and Drug Administration voted unanimously on Wednesday that the approval of Avastin as a treatment for breast cancer should be revoked, despite a two-day appeal hearing by Genentech, the drug’s manufacturer.…